Daughters of Penelope Host Breast Cancer Seminar
Medical experts share critical guidance on early detection and modern treatment at a New York City awareness event.
Updated on Oct. 25, 2026 in Cancer
Live Poll
Do you make it a priority to schedule annual health screenings for yourself or your family?
The Daughters of Penelope Evryklea Chapter 36 held a breast cancer awareness event at the Consulate General of Greece in New York on October 23, 2026. Experts provided insights into prevention strategies, screening timelines, and advancements in surgical oncology.
Why it matters
The session aimed to educate the local community on the importance of early detection and the evolving standards for breast cancer treatment. By clarifying screening guidelines, the event sought to improve health outcomes for those at varying levels of risk.
A stage one breast cancer diagnosis currently yields a 99% cure rate. Medical protocols for screening recommend starting mammograms at age 40, or earlier for individuals with specific genetic mutations like BRCA or significant family histories.
The players
Daughters of Penelope Evryklea Chapter 36
This is a local chapter of the international women's organization that promotes Hellenism, education, and philanthropy.
Dr. Karen Hiotis
She is a medical professional who presented information on breast cancer prevention and treatment options.
Dr. Lorraine Chrisomalis-Valasiadis
She is a medical professional who shared insights on breast cancer awareness and shared her personal connection to survivorship.
Consulate General of Greece in New York
This diplomatic mission serves as the official representative office of the Greek government in New York City.
The details
Dr. Karen Hiotis and Dr. Lorraine Chrisomalis-Valasiadis detailed surgical improvements such as nipple-sparing mastectomies and decreased lymph node removal requirements. They emphasized that diagnosis involves mammograms and ultrasounds, particularly for patients with dense breast tissue.
Timeline
The event occurred on October 23, 2026.
Dr. George Raptis checked HER2 neu markers in 1992.
Health Landscape
This event reflects the ongoing evolution of breast cancer care since the 1992 discovery of HER2 neu markers. Modern practice now emphasizes shifting away from aggressive lymph node removal in favor of targeted, tissue-sparing surgical interventions.
Residents should consult their doctors regarding a personalized screening schedule based on their specific family history and age. This information helps patients weigh the benefits of early imaging against the reduced necessity for invasive surgical procedures.
The takeaway
Early detection remains the most effective tool in achieving a high cure rate for breast cancer patients. Understanding your personal risk factors and adhering to recommended screening timelines can significantly improve long-term health outcomes.
What happens next
The Daughters of Penelope Evryklea Chapter 36 is scheduled to host a future event focused on property issues and the land registry in Greece.
Further reading
For more information on screening guidelines and oncology trends, visit the Cancer section.
Source note: This article includes information reported by The National Herald.
Live Poll
Do you make it a priority to schedule annual health screenings for yourself or your family?
